This site is intended for healthcare professionals
Drug news

Interim Phase III data for Arzerra in CLL meets primary endpoint - Genmab

Read time: 1 mins
Last updated:8th Nov 2014
Published:8th Nov 2014
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest